Heard on the Street: Pharmaceutical companies are opting to make smaller biotech acquisitions. That’s great news for biotech stocks.

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading